日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Muscadine grape skin extract inhibits prostate cancer cells by inducing cell-cycle arrest, and decreasing migration through heat shock protein 40

麝香葡萄皮提取物通过诱导细胞周期停滞和减少热休克蛋白 40 的迁移来抑制前列腺癌细胞

Diane N Ignacio, Kimberly D Mason, Ezra C Hackett-Morton, Christopher Albanese, Lymor Ringer, William D Wagner, Paul C Wang, Michael A Carducci, Sushant K Kachhap, Channing J Paller, Janet Mendonca, Leo Li-Ying Chan, Bo Lin, Diane K Hartle, Jeffrey E Green, Collis A Brown, Tamaro S Hudson1

Interplay between hypoxia and androgen controls a metabolic switch conferring resistance to androgen/AR-targeted therapy

缺氧和雄激素之间的相互作用控制着一种代谢转换,这种转换赋予了对雄激素/AR 靶向治疗的抵抗力

Hao Geng, Changhui Xue, Janet Mendonca, Xiao-Xin Sun, Qiong Liu, Patrick N Reardon, Yingxiao Chen, Kendrick Qian, Vivian Hua, Alice Chen, Freddy Pan, Julia Yuan, Sang Dang, Tomasz M Beer, Mu-Shui Dai, Sushant K Kachhap, David Z Qian

C/EBPβ regulates sensitivity to bortezomib in prostate cancer cells by inducing REDD1 and autophagosome-lysosome fusion

C/EBPβ通过诱导REDD1和自噬体-溶酶体融合调节前列腺癌细胞对硼替佐米的敏感性

David J Barakat, Janet Mendonca, Theresa Barberi, Jing Zhang, Sushant K Kachhap, Ido Paz-Priel, Alan D Friedman

Combining the pan-aurora kinase inhibitor AMG 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancer

将泛极光激酶抑制剂 AMG 900 与组蛋白去乙酰化酶抑制剂联合使用可增强前列腺癌的抗肿瘤活性

Channing J Paller, Michel D Wissing, Janet Mendonca, Anup Sharma, Eugene Kim, Hea-Soo Kim, Madeleine S Q Kortenhorst, Stephanie Gerber, Marc Rosen, Faraz Shaikh, Marianna L Zahurak, Michelle A Rudek, Hans Hammers, Charles M Rudin, Michael A Carducci, Sushant K Kachhap

Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells

西曲溴铵和伊立替康作为对 NDRG1 缺陷前列腺癌细胞具有合成杀伤力的化合物的鉴定

Michel D Wissing, Janet Mendonca, Eunice Kim, Eugene Kim, Joong S Shim, Nadine S Kaelber, Huub Kant, Hans Hammers, Therese Commes, Paul J Van Diest, Jun O Liu, Sushant K Kachhap

Targeting prostate cancer cell lines with polo-like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors

使用 polo 样激酶 1 抑制剂作为单一药物以及与组蛋白去乙酰化酶抑制剂联合作用于前列腺癌细胞系

Michel D Wissing, Janet Mendonca, Madeleine S Q Kortenhorst, Nadine S Kaelber, Matthew Gonzalez, Eunice Kim, Hans Hammers, Paul J van Diest, Michael A Carducci, Sushant K Kachhap